Category Archives: Patient Communication
ePharma Summit: Turning Big Data into Better Content
Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?
Also posted in Advertising, E-Media, Events, FDA, Marketing, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media Tagged digital marketing, ePharma Summit, patient education, patient engagement, Professional Marketing Leave a comment
Reflections on Rare Disease Day
The rare disease advocacy community convened yesterday for its annual Rare Disease Day celebration, marking another year of advances in the fight against ailments once almost entirely ignored by big Pharma. The fact that hundreds of rare diseases are finally attracting real attention from major researchers, not to mention big dollars, is attributable not [...]
Also posted in Europe, FDA, Market Access, Orphan Drugs, Regulatory Tagged Rare Disease Day, rare diseases Leave a comment
UN Pact Scuttles Anti-Vaccine Provision
A new international agreement to reduce mercury contamination of air and water was recently adopted by 140 countries, without a proposal that threatened to limit access to vaccines in much of the world. The credit goes to public health authorities and medical experts who challenged a provision blocking production of vaccines with the preservative thimerosal, [...]
Also posted in Emerging Markets, FDA, Global, Legal, Market Access, Safety, healthcare Tagged autism, developing countries, patient advocates, patient groups, thimerosol, vaccines, WHO 1 Comment

Changing the DNA of Pharma Patient Adherence Programs